Pathogenesis of M.pneumoniae Reactive Airway Disease
Pathogenesis of M.pneumoniae Reactive Airway Disease
批准号:
6612598
负责人:
ROBERT DOUG HARDY
金额:
$10.8万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2008-01-31
关键词:
Mycoplasma pneumoniae asthma bacteria infection mechanism cellular immunity cytokine disease /disorder model enzyme linked immunosorbent assay flow cytometry gene targeting genetically modified animals immunocytochemistry in situ hybridization inflammation interferon gamma interleukin 12 laboratory mouse pathologic process plethysmography polymerase chain reaction respiratory airflow disorder respiratory infections
中文摘要
描述(由申请人提供):哮喘的发病率和患病率在过去几十年中急剧增加。CDC估计,在1998年,哮喘影响了美国约1700万人或6.4%的人口。肺炎支原体被认为是儿童和成人急性下呼吸道感染的常见病原体。最近M。肺炎与反应性气道疾病和哮喘有关。目的探讨M.肺炎支原体在呼吸道的感染及其在哮喘中的潜在作用,我们建立了急性和慢性肺炎支原体感染的小鼠模型。肺炎呼吸道感染,表现为气道阻塞、气道高反应性和肺部炎症。我们的初步研究结果以及其他研究者的研究结果表明,下呼吸道中TH1和TH2细胞因子的产生可能在M的急性表现和慢性后遗症中起重要作用。肺炎感染。这个建议的中心假设是M。肺炎下呼吸道感染导致肺中TH1和TH2细胞因子表达的改变,并且这些细胞因子参与气道阻塞、气道高反应性增加和组织学炎症的发展。我们相信,这项研究可能最终导致新的免疫调节策略,以治疗儿童和成人感染相关的反应性气道疾病和哮喘。
候选人的直接职业目标是获得基础科学调查方面的进一步培训,这将提高他的研究技能,使他成为一名独立的调查员。作为职业重点,候选人打算专注于宿主微生物病原体关系的免疫发病机制。为了实现这一目标,研究提案要求获得新的科学技术和知识技能,同时调查一个及时的研究课题。德克萨斯大学西南医学中心提供了一个肥沃的环境,无论是在实验室资产和经验丰富,致力于这项研究和候选人的职业发展所需的教师。该奖项将促进并确保候选人最终过渡到一个独立的,学术的物理学家,科学家。
英文摘要
DESCRIPTION (provided by applicant): The incidence and prevalence of asthma has dramatically increased in the last decades. The CDC estimated that in 1998 asthma affected approximately 17 million people in the United States or 6.4% of the population. Mycoplasma pneumoniae is recognized as a common etiologic agent of acute lower respiratory infection in children and adults. More recently M. pneumoniae has been associated with reactive airway disease and asthma. To study the pathogenesis of M. pneumoniae infection in the respiratory tract and its potential role in asthma, we have established a murine model of acute and chronic M. pneumoniae respiratory infection that manifests airway obstruction, airway hyperreactivity, and pulmonary inflammation. Results from our initial studies, as well as from other investigators, indicate that the production of TH1 and TH2 cytokines in the lower respiratory tract may play an important role in both the acute manifestations and chronic sequelae of M. pneumoniae infection. The central hypothesis of this proposal is that M. pneumoniae lower respiratory tract infection leads to alterations in the pulmonary expression of TH1 and TH2 cytokines and that these cytokines are involved in the development of airway obstruction, increased airway hyperreactivity, and histologic inflammation. We believe that this research may ultimately result in new immunomodulatory strategies to treat children and adults with infection-associated reactive airway disease and asthma.
The immediate career goal of the candidate is to procure further training in basic science investigation that will enhance his research skills and allow him to become an independent investigator. As a career focus, the candidate intends to concentrate on the immunopathogenesis of the host microbial pathogen relationship. To achieve this goal, the research proposal calls for the attainment of new scientific technical and intellectual skills while concurrently investigating a timely research topic. The University of Texas Southwestern Medical Center provides a fertile environment both in terms of laboratory assets and experienced, committed faculty necessary for this research and the candidate's career development. This award will facilitate and ensure the eventual transition of the candidate into an independent, academic physician-scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Mycoplasma pneumoniae Toxin as Mediator of Airway Dysfunction in Mice
-
批准号:7686467
-
项目类别:
-
资助金额:$23.98万
-
财政年份:2008
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Novel Mycoplasma pneumoniae CARDS Toxin as Mediator of Airway Dysfuntion in Mice
-
批准号:7150756
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2006
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Pathogenesis of M.pneumoniae Reactive Airway Disease
-
批准号:6730559
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2003
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Pathogenesis of M.pneumoniae Reactive Airway Disease
-
批准号:6846095
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2003
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Pathogenesis of M.pneumoniae Reactive Airway Disease
-
批准号:7178454
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2003
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Pathogenesis of M.pneumoniae Reactive Airway Disease
-
批准号:7012708
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2003
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Novel Mycoplasma pneumoniae CARDS Toxin as Mediator of Airway Dysfuntion in Mice
-
批准号:7557459
-
项目类别:
-
资助金额:$26.44万
-
财政年份:--
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Novel Mycoplasma pneumoniae Toxin as Mediator of Airway Dysfunction in Mice
-
批准号:7904185
-
项目类别:
-
资助金额:$21.12万
-
财政年份:--
-
负责人:ROBERT DOUG HARDY
-
依托单位:
Novel Mycoplasma pneumoniae Toxin as Mediator of Airway Dysfunction in Mice
-
批准号:8126241
-
项目类别:
-
资助金额:$21.36万
-
财政年份:--
-
负责人:ROBERT DOUG HARDY
-
依托单位:
海外基金